ERBB2 and breast carcinoma: Identification of Stattic and in vitro findings in MDA-MB-435S and MDA-MB-456 cells; Stattic treatment decreases cell survival of MCF7-HER2 cells in vitro; In vitro findings with doxorubicin on ZR-75-1 breast cancer cells.